Literature DB >> 16081685

MEK kinase 1 activity is required for definitive erythropoiesis in the mouse fetal liver.

Barbara Bonnesen1, Cathrine Orskov, Susanne Rasmussen, Peter Johannes Holst, Jan Pravsgaard Christensen, Karsten Wessel Eriksen, Klaus Qvortrup, Niels Odum, Tord Labuda.   

Abstract

Mitogen-activated protein kinase/extracellular signal to regulated kinase (MEK) kinase 1 (MEKK1) is a c-Jun N-terminal kinase (JNK) activating kinase known to be implicated in proinflammatory responses and cell motility. Using mice deficient for MEKK1 kinase activity (Mekk1(DeltaKD)) we show a role for MEKK1 in definitive mouse erythropoiesis. Although Mekk1(DeltaKD) mice are alive and fertile on a 129 x C57/BL6 background, the frequency of Mekk1(DeltaKD) embryos that develop past embryonic day (E) 14.5 is dramatically reduced when backcrossed into the C57/BL6 background. At E13.5, Mekk1(DeltaKD) embryos have normal morphology but are anemic due to failure of definitive erythropoiesis. When Mekk1(DeltaKD) fetal liver cells were transferred to lethally irradiated wild-type hosts, mature red blood cells were generated from the mutant cells, suggesting that MEKK1 functions in a non-cell-autonomous manner. Based on immunohistochemical and hemoglobin chain transcription analysis, we propose that the failure of definitive erythropoiesis is due to a deficiency in enucleation activity caused by insufficient macrophage-mediated nuclear DNA destruction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081685     DOI: 10.1182/blood-2005-04-1739

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  JNK1, but not JNK2, is required in two mechanistically distinct models of inflammatory arthritis.

Authors:  Katja Denninger; Susanne Rasmussen; Jeppe Madura Larsen; Catrine Orskov; Steen Seier Poulsen; Poul Sørensen; Jan Pravsgaard Christensen; Harald Illges; Niels Odum; Tord Labuda
Journal:  Am J Pathol       Date:  2011-08-11       Impact factor: 4.307

Review 2.  The erythroblastic island.

Authors:  Deepa Manwani; James J Bieker
Journal:  Curr Top Dev Biol       Date:  2008       Impact factor: 4.897

Review 3.  In vivo functions of mitogen-activated protein kinases: conclusions from knock-in and knock-out mice.

Authors:  Nancy Gerits; Sergiy Kostenko; Ugo Moens
Journal:  Transgenic Res       Date:  2007-01-12       Impact factor: 3.145

4.  The MEKK1 PHD ubiquitinates TAB1 to activate MAPKs in response to cytokines.

Authors:  Nikolaos Charlaftis; Tesha Suddason; Xuefeng Wu; Saba Anwar; Michael Karin; Ewen Gallagher
Journal:  EMBO J       Date:  2014-09-26       Impact factor: 11.598

Review 5.  A RING to rule them all? Insights into the Map3k1 PHD motif provide a new mechanistic understanding into the diverse roles of Map3k1.

Authors:  T Suddason; E Gallagher
Journal:  Cell Death Differ       Date:  2015-01-23       Impact factor: 15.828

6.  Signal, transduction, and the hematopoietic stem cell.

Authors:  Igal Louria-Hayon
Journal:  Rambam Maimonides Med J       Date:  2014-10-29

7.  The PHD motif of Map3k1 activates cytokine-dependent MAPK signaling.

Authors:  Ewen Gallagher; Tesha Suddason
Journal:  Mol Cell Oncol       Date:  2015-05-06

Review 8.  Genetic Control of MAP3K1 in Eye Development and Sex Differentiation.

Authors:  Jingjing Wang; Eiki Kimura; Maureen Mongan; Ying Xia
Journal:  Cells       Date:  2021-12-23       Impact factor: 6.600

9.  Minor abnormalities of testis development in mice lacking the gene encoding the MAPK signalling component, MAP3K1.

Authors:  Nick Warr; Debora Bogani; Pam Siggers; Rachel Brixey; Hilda Tateossian; Asha Dopplapudi; Sara Wells; Michael Cheeseman; Ying Xia; Harry Ostrer; Andy Greenfield
Journal:  PLoS One       Date:  2011-05-03       Impact factor: 3.240

10.  T-Cell-Specific Deletion of Map3k1 Reveals the Critical Role for Mekk1 and Jnks in Cdkn1b-Dependent Proliferative Expansion.

Authors:  Tesha Suddason; Saba Anwar; Nikolaos Charlaftis; Ewen Gallagher
Journal:  Cell Rep       Date:  2016-01-07       Impact factor: 9.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.